Cite
Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma.
MLA
Gogineni, Emile, et al. “Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma.” Cancers, vol. 16, no. 6, Mar. 2024, p. 1204. EBSCOhost, https://doi.org/10.3390/cancers16061204.
APA
Gogineni, E., Sells, B. E., Dibs, K., Jhawar, S. R., Haring, C. T., Limbach, A. L., Konieczkowski, D. J., Ma, S. J., Zhu, S., Baliga, S., Mitchell, D. L., Grecula, J. C., Bonomi, M., Bhateja, P., Old, M. O., Seim, N. B., Kang, S. Y., Rocco, J. W., Chakravarti, A., & Blakaj, D. M. (2024). Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma. Cancers, 16(6), 1204. https://doi.org/10.3390/cancers16061204
Chicago
Gogineni, Emile, Blake E. Sells, Khaled Dibs, Sachin R. Jhawar, Catherine T. Haring, Abberly L. Limbach, David J. Konieczkowski, et al. 2024. “Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma.” Cancers 16 (6): 1204. doi:10.3390/cancers16061204.